+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling



Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling



Chinese Medical Journal 115(8): 1166-1169



Objective: To investigate the effect of chronic treatment of enbrel (EB), a TNF-alpha antagonist, in a well defined congestive heart failure (CHF) rat model and test the hypothesis that chronic treatment of EB in CHF rats may limit the progression of Left ventricular (LV) dysfunction and structure remodeling and decrease cardiac IL-1beta levels. Methods: We measured cardiac conformation, contractile performance and cytokines level in 8 age-matched normal adult rats (control group) and 8 rats with isoproterenol (ISO)-induced Heart failure (ISO group) and 8 rats with ISO-induced lesion but received EB treatment (EB group). Results: LV end diastolic diameter and LV end systolic diameter in EB group were significantly less and LV fractional shortening was significantly larger than ISO group (9.2+-0.3 mm vs 9.5+-0.2 mm, 5.8+-0.5 mm vs 6.5+-0.3 mm, 0.37+-0.03 vs 0.31+-0.02, P<0.05, P<0.01, P<0.01 respectively), but there was no significant difference of LV posterior wall thickness at end diastole between the two groups; LV end systolic pressure (PES), dp/dtmax in EB group were significantly greater than ISO group (104.8+-4.6 mm Hg vs 98.4+-4.9 mm Hg, 8395+-940 mm Hg/s vs 6898+-612 mm Hg, P<0.05, P<0.01 respectively), and LV end diastolic pressure (PED), dp/dtmin, time constant of LV relaxation were significantly lower than ISO group (3.8+-0.6 mm Hg vs 7.1+-0.8 mm Hg, -5963+-475 mm Hg/s vs -5030+-316 mm Hg/s, 15.4+-0.8 ms vs 21.3+-1.4 ms, P<0.01, respectively). Although cardiac contractile performance in the EB group was greatly improved, there still was a big gap when compared with the control group. The ratio of LV weight to body weight in the EB group was significantly higher than control group (2.82+-0.07 mg/g vs 2.28+-0.08 mg/g, P<0.01), but there was no significant difference when compared with the ISO group. There was no significant difference between the serum level of TNF-alpha in EB group and ISO group, the it could not be detected in control group. TNF-alpha levels in LV of EB group was significantly higher than control group, (757.6+-46.8 pg/g vs 367.5+-22.7 pg/g, P<0.01), but there was no significant difference when compared with ISO group. The IL-1beta level in LV of EB group was significantly lower than ISO group (356.2+-28.5 pg/g vs 518.4+-32.5 pg/g, P<0.05), and it could not be detected in control group. The serum level of IL-1beta could not be detected in any rats. Conclusion: EB administered as soon as possible when ISO induced myocardial necrosis occurs can greatly improve cardiac contraction, and the improvement may be partly due to a decrease in the IL-1beta level in LV, besides the direct blocking effect of EB on TNF-alpha. EB can alleviate cardiac remodeling by its effect on LVEDD.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010322734

Download citation: RISBibTeXText

PMID: 12215284


Related references

Regression of left ventricular remodeling in chronic heart failure after treatment with ENBREL. Circulation 100(18 SUPPL ): I 645, Nov 2, 1999

Effects of bone marrow mesenchymal stem cells transplantation on heart function and ventricular remodeling in rats with isoproterenol-induced congestive heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 37(4): 347-351, 2010

Surgical ventricular remodeling for patients with clinically advanced congestive heart failure and severe left ventricular dysfunction. Journal of Heart and Lung Transplantation 24(12): 2202-2210, 2005

Alteration in left ventricular function induced by dihydralazine in severe chronic congestive heart failure: limits of vasodilator therapy?. La Nouvelle Presse Medicale 9(19): 1384-1384, 1980

Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure. International Journal of Molecular Medicine 21(1): 117-124, 2008

Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure. International Journal of Molecular Medicine 21(1): 117-124, 2007

Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction. Journal of Cardiology 59(3): 359-365, 2013

Cardio-protecteffect of qiliqiangxin capsule on left ventricular remodeling, dysfunction and apoptosis in heart failure rats after chronic myocardial infarction. American Journal of Translational Research 8(5): 2047-2058, 2016

Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction. American Journal of Cardiology 88(6): 624-629, September 15, 2001

Frontiers in congestive heart failure: Comparison of candesartan, enalapril, and their combination in congestive heart failure—Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVED) pilot study. Congestive Heart Failure 5(6): 286-287, 2002

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82(5): 1724-1729, 1990

Vasodilators have not been shown to be of value in all patients with chronic congestive heart failure due to left ventricular systolic dysfunction. American Journal of Cardiology 66(4): 435-438, 1990

Curcumin attenuates left ventricular dysfunction and remodeling in rabbits with chronic heart failure.. Zhonghua Xin Xue Guan Bing Za Zhi 37(3): 262-267, 2016

Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure. Journal of Cardiovascular Pharmacology 56(5): 506-512, 2011

Frontiers in congestive heart failure: Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction. Congestive Heart Failure 5(3): 131-132, 2002